| 1 |
Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling[J]. N Engl J Med, 1989, 321(17): 1174-1178.
|
| 2 |
Milano F, Appelbaum FR, Delaney C. Cord-blood transplantation in patients with minimal residual disease[J]. N Engl J Med, 2016, 375(22): 2204-2205.
|
| 3 |
Hiwarkar P, Qasim W, Ricciardelli I, et al. Cord blood T cells mediate enhanced antitumor effects compared with adult peripheral blood T cells[J]. Blood, 2015, 126(26): 2882-2891.
|
| 4 |
Mayani H, Wagner JE, Broxmeyer HE. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives[J]. Bone Marrow Transplant, 2019, 55(1): 48-61.
|
| 5 |
Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy[J]. Blood, 2005, 105(3): 1343-1347.
|
| 6 |
Verneris MR, Brunstein CG, Barker J, et al. Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units[J]. Blood, 2009, 114(19): 4293-4299.
|
| 7 |
Ruggeri A, Sanz G, Bittencourt H, et al. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT[J]. Leukemia, 2014, 28(4): 779-786.
|
| 8 |
Wagner JE Jr, Eapen M, Carter S, et al. One-unit versus two-unit cord-blood transplantation for hematologic cancers[J]. N Engl J Med, 2014, 371(18): 1685-1694.
|
| 9 |
Michel G, Galambrun C, Sirvent A, et al. Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome[J]. Blood, 2016, 127(26): 3450-3457.
|
| 10 |
Dahlberg A, Woo S, Delaney C, et al. Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity[J]. Leukemia, 2015, 29(9): 1948-1951.
|
| 11 |
Delaney C, Heimfeld S, Brashem-Stein C, et al. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution[J]. Nat Med, 2010, 16(2): 232-236.
|
| 12 |
Peled T, Mandel J, Goudsmid RN, et al. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine[J]. Cytotherapy, 2004, 6(4): 344-355.
|
| 13 |
de Lima M, McMannis J, Gee A, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase Ⅰ/Ⅱ clinical trial[J]. Bone Marrow Transplant, 2008, 41(9): 771-778.
|
| 14 |
Stiff PJ, Montesinos P, Peled T, et al. Cohort-controlled comparison of umbilical cord blood transplantation using carlecortemcel-L, a single progenitor-enriched cord blood, to double cord blood unit transplantation[J]. Biol Blood Marrow Transplant, 2018, 24(7): 1463-1470.
|
| 15 |
Peled T, Shoham H, Aschengrau D, et al. Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment[J]. Exp Hematol, 2012, 40(4): 342-355.
|
| 16 |
Horwitz ME, Wease S, Blackwell B, et al. Phase Ⅰ/Ⅱ study of stem-cell transplantation using a single cord blood unit expanded ex vivo with nicotinamide[J]. J Clin Oncol, 2019, 37(5): 367-374.
|
| 17 |
Horwitz ME, Chao NJ, Rizzieri DA, et al. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment[J]. J Clin Invest, 2014, 124(7): 3121-3128.
|
| 18 |
Anand S, Thomas S, Hyslop T, et al. Transplantation of ex vivo expanded umbilical cord blood (NiCord) decreases early infection and hospitalization[J]. Biol Blood Marrow Transplant, 2017, 23(7): 1151-1157.
|
| 19 |
Leung A, Zulick E, Skvir N, et al. Notch and aryl hydrocarbon receptor signaling impact definitive hematopoiesis from human pluripotent stem cells[J]. Stem Cells, 2018, 36(7): 1004-1019.
|
| 20 |
Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells[J]. Science, 2010, 329(5997): 1345-1348.
|
| 21 |
Wagner JE Jr, Brunstein CG, Boitano AE, et al. Phase Ⅰ/Ⅱ trial of StemRegenin-1 expandedumbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft[J]. Cell Stem Cell, 2016, 18(1): 144-155.
|
| 22 |
Robinson SN, Simmons PJ, Yang H, et al. Mesenchymal stem cells in ex vivo cord blood expansion[J]. Best Pract Res Clin Haematol, 2011, 24(1): 83-92.
|
| 23 |
Zhao D, Liu L, Chen Q, et al. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34+ cells[J]. Stem Cell Res Ther, 2018, 9(1): 158.
|
| 24 |
Lo Iacono M, Russo E, Anzalone R, et al. Wharton's jelly mesenchymal stromal cells support the expansion of cord blood-derived CD34+ cells mimicking a hematopoietic niche in a direct cell-cell contact culture system[J]. Cell Transplant, 2018, 27(1): 117-129.
|
| 25 |
郝思国, 孙关林, 邬维礼, 等. 骨髓基质细胞共培养体系促进人脐血CD133+细胞的体外扩增[J]. 中华器官移植杂志, 2005, 26(1): 28-32.
|
| 26 |
de Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture[J]. N Engl J Med, 2012, 367(24): 2305-2315.
|
| 27 |
Baron F, Ruggeri A, Nagler A. Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications[J]. Expert Rev Hematol, 2016, 9(3): 297-314.
|
| 28 |
Thompson PA, Rezvani K, Hosing CM, et al. Umbilical cord blood graft engineering: challenges and opportunities[J]. Bone Marrow Transplant, 2015, 50(): S55-S62.
|
| 29 |
Frassoni F, Gualandi F, Podesta M, et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase Ⅰ/Ⅱ study[J]. Lancet Oncol, 2008, 9(9): 831-839.
|
| 30 |
Murata M, Maeda Y, Masuko M, et al. Phase Ⅱ study of intrabone single unit cord blood transplantation for hematological malignancies[J]. Cancer Sci, 2017, 108(8): 1634-1639.
|
| 31 |
Okada M, Tasaka T, Ikegame K, et al. A prospective multicenter phase Ⅱ study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning[J]. Eur J Haematol, 2018, 100(4): 335-343.
|
| 32 |
Bonifazi F, Dan E, Labopin M, et al. Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study[J]. Bone Marrow Transplant, 2019, 54(5): 717-725.
|
| 33 |
Hagedorn EJ, Durand EM, Fast EM, et al. Getting more for your marrow: boosting hematopoietic stem cell numbers with PGE2[J]. Exp Cell Res, 2014, 329(2): 220-226.
|
| 34 |
Hoggatt J, Singh P, Sampath J, et al. Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation[J]. Blood, 2009, 113(22): 5444-5455.
|
| 35 |
Cutler C, Multani P, Robbins D, et al. Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation[J]. Blood, 2013, 122(17): 3074-3081.
|
| 36 |
van Besien K, Hari P, Zhang MJ, et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival[J]. Haematologica, 2016, 101(5): 634-643.
|
| 37 |
Hsu J, Artz A, Mayer SA, et al. Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation for high-risk lymphoma and chronic lymphoblastic leukemia[J]. Biol Blood Marrow Transplant, 2018, 24(2): 359-365.
|
), 郝思国(